The research group, made up of members from several institutions, including Joaquim Chaves Saúde, identified a new molecule that may have the potential to reverse or prevent cognitive impairment in Alzheimer's patients.
During part of the research, which took place at Laboratório CORE (Greater Lisbon), samples were taken for biochemical measurements in serum. During this process, the following parameters were assessed:
• Creatine kinase (assessment of muscle damage);
• Creatinine and urea (determination of kidney function);
• Aspartate and alanine aminotransferases - AST and ALT - (assessment of liver damage).
In practice, the Laboratório Dr. Joaquim Chaves has helped to demonstrate that the molecule in question is safe, since it has not shown any toxicity, either on a renal or hepatic level.
Participation in this research once again puts Joaquim Chaves Saúde at the forefront of laboratory research.
The study has been published on the website of the journal “Molecular Therapy” and can be consulted in full here.